Authors
Latest:
Where Do We Go From Here?Lessons from six months of conducting clinical trials during the COVID-19 pandemic
Latest:
Establishing a Basis for Secondary Use Standards for Clinical TrialsStudy seeks to understand how different forms of data meet the needs of researchers.
Latest:
How Remote Patient Monitoring Technology Can Impact Decentralized Clinical TrialsWhat is next for DCTs after acceleration from COVID-19?
Latest:
Tailored Patient Involvement in Clinical TrialsThe approach of the Cancer Research UK Centre for Drug Development.
Latest:
Reviewing FDA’s Proposed IRB and Informed Consent Rule Changes21st Century Cures Act prompts FDA to harmonize regulations.
Latest:
Scale Your Top Digital Stars in 2024—Not Just Generate New OnesScaling seven common digital programs inside a typical top 10 pharma company could be worth $1.4 billion to $2.2 billion in operating income over five years.
Latest:
Strategies to Close the Gap in Clinical Trial Recruitment2021 survey highlights challenges and opportunities for investigators, coordinators, and patients.
Latest:
Navigating Evolving DEI Measures in Clinical Patient Recruitment: A Deep DiveIt is crucial throughout the clinical trials space to understand the challenges and triumphs of DEI.
Latest:
AI/ML Approaches to Assisted Medical Writing—Part 2Following a discussion around summarization in Part 1, Part 2 discusses the method of pure abstraction in light of recent advances in deep learning and AI.
Latest:
Clinical Trials and TrustUnderstanding the role of social determinants on clinical trial participation and trust.
Latest:
Rethinking ECOG Scores to Improve Patient Access and Clinical Trials EligibilityRecent study results highlight need for new metrics in ECOG scoring to mitigate variability.
Latest:
Improving Diversity in Clinical Trial Volunteer Participation by Addressing Racial and Ethnic Representation Among the Clinical Research Workforce2020 Tufts CSDD study examines relationship between investigative site personnel diversity and study participant diversity.
Latest:
Adapting Site Selection for Clinical Trial Decentralization and the Future LandscapeSites not expected to fade away even as DCTs continue to grow past COVID-19.
Latest:
Sharing Anonymized and Functionally Effective (SAFE) Data Standard for Safely Sharing Rich Clinical Trial DataPresenting how data transformation is measured as part of the SAFE Data Standard, which data variables influence the rating and, how the appropriate level of data transformation is calculated.
Latest:
COVID-19 Pandemic Exemplifies the Benefits of CROsThe adaptability and innovative capacity of CROs highlighted in EUCROF survey.
Latest:
Breaking Historic Barriers to Ensure Psychedelic Therapy’s FutureEducation and equitable access are key to unlocking its full potential in the present and future.
Latest:
Diversity in Clinical Trial Data Transparency: A New Horizon for Data Sharing with Truthful StatisticsThe pursuit of balance between data utility, privacy protection, and equitable representation.
Latest:
Real-World Use of an Artificial Intelligence-Supported Solution for Coding of Adverse Events in Clinical TrialsStudy evaluates the use of AI-supported medical coding module.
Latest:
COVID-19 Will Have a Heterogeneous Impact on Clinical Trials, BiopharmasA discussion of how the coronavirus pandemic will have a multitude of impacts on the conduct of trials, as well as on the industry itself.
Latest:
Diversity in Clinical Trials: Path to Achieving Health EquityBeyond technology, awareness, and access—cultural competence is key.
Latest:
Sample Size Re-Estimation as an Adaptive DesignUsing the promising-zone approach can salvage an underpowered trial.
Latest:
Clinical Trial Optionality: Its Reality is Within ReachHow advanced ePRO tools and approaches offer a path forward.
Latest:
How Digital Twins are Driving Sustainability in Clinical Supply PlanningEmerging technologies like digital twins offer supply chain efficiency solutions, allowing the industry to integrate sustainable practices while ensuring patient safety.
Latest:
Smart New Normal in Medication Management—Personalized, Integrated, and FlexibleWhat the next generation medication management in clinical trials should entail and insights on smart technologies and synergistic partnerships—backed by real-life implementation use cases.
Latest:
Optimizing Patient Recruitment and Engagement StrategiesFive strategies to reduce risk and achieve deadlines.
Latest:
Establishing Metrics and Standardization for Non-CRF Data in EDCWhile Case Report Forms are a main contributor to collected data, non-CRF data such as core laboratory data and central imaging can be critical to any clinical study.
Latest:
A New Era in Clinical TrialsIndustry challenges present an opportunity for innovation and the adoption of new solutions, particularly in addressing barriers related to patient recruitment, engagement, and retention.
Latest:
Artificial Intelligence Drives Industry Response to Project OptimusThe FDA has taken a clear position with Project Optimus in shifting toward more progressive tailored approaches while rejecting antiquated study designs to evolve clinical trial strategies to better align with newer drug classes.
